115. Immune-modulation therapy in a CRIM negative Pompe disease patient blocks antibody formation towards Myozyme, reverses cardiomyopathy, and prolongs survival
Publication
, Journal Article
Rhead, W; Wells, C; Margolis, D; Kishnani, P
Published in: Molecular Genetics and Metabolism
February 2009
Duke Scholars
Published In
Molecular Genetics and Metabolism
DOI
ISSN
1096-7192
Publication Date
February 2009
Volume
96
Issue
2
Start / End Page
S37 / S37
Publisher
Elsevier BV
Related Subject Headings
- Genetics & Heredity
- 3202 Clinical sciences
- 3105 Genetics
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Rhead, W., Wells, C., Margolis, D., & Kishnani, P. (2009). 115. Immune-modulation therapy in a CRIM negative Pompe disease patient blocks antibody formation towards Myozyme, reverses cardiomyopathy, and prolongs survival. Molecular Genetics and Metabolism, 96(2), S37–S37. https://doi.org/10.1016/j.ymgme.2008.11.116
Rhead, William, Cara Wells, David Margolis, and Priya Kishnani. “115. Immune-modulation therapy in a CRIM negative Pompe disease patient blocks antibody formation towards Myozyme, reverses cardiomyopathy, and prolongs survival.” Molecular Genetics and Metabolism 96, no. 2 (February 2009): S37–S37. https://doi.org/10.1016/j.ymgme.2008.11.116.
Rhead W, Wells C, Margolis D, Kishnani P. 115. Immune-modulation therapy in a CRIM negative Pompe disease patient blocks antibody formation towards Myozyme, reverses cardiomyopathy, and prolongs survival. Molecular Genetics and Metabolism. 2009 Feb;96(2):S37–S37.
Rhead, William, et al. “115. Immune-modulation therapy in a CRIM negative Pompe disease patient blocks antibody formation towards Myozyme, reverses cardiomyopathy, and prolongs survival.” Molecular Genetics and Metabolism, vol. 96, no. 2, Elsevier BV, Feb. 2009, pp. S37–S37. Crossref, doi:10.1016/j.ymgme.2008.11.116.
Rhead W, Wells C, Margolis D, Kishnani P. 115. Immune-modulation therapy in a CRIM negative Pompe disease patient blocks antibody formation towards Myozyme, reverses cardiomyopathy, and prolongs survival. Molecular Genetics and Metabolism. Elsevier BV; 2009 Feb;96(2):S37–S37.
Published In
Molecular Genetics and Metabolism
DOI
ISSN
1096-7192
Publication Date
February 2009
Volume
96
Issue
2
Start / End Page
S37 / S37
Publisher
Elsevier BV
Related Subject Headings
- Genetics & Heredity
- 3202 Clinical sciences
- 3105 Genetics
- 1103 Clinical Sciences